...-implied ratings for Bristol-Myers (BMY) are currently Aaa -- the highest attainable level. Over the last year these market signals have remained within a very tight band, never falling below Aa1 (Figure 1). BMY s five-year CDS mid-spread is currently 22 bp, 16 bp tighter than it s 38 bp a year ago. The bond-implied rating for BMY has been a bit lower -- currently A1 -- and has shown somewhat more volatility. Over the last three months it fluctuated between Aa3 and A2. The bond-implied rating s A2 low point on May 5 followed the April 29 first-quarter earnings announcement of profits up 4.5% and above analyst expectations, but revenues down 2.9%, below Wall Street s forecasts, and the acquisition of iPierian....